[logo] HealthTree Foundation
search person
chevron_left Bispecific Antibodies to Treat Multiple Myeloma: An Educational Guide

Future Considerations of Bispecific Antibody Therapy

Last updated on: 10/18/2024

The rapid research being done in the myeloma treatment field means that what we know about current therapies can continue to evolve. With bispecifics being so relatively new as a myeloma treatment, we are certain to see changes as it evolves. 

The following sections will detail information like: 

  • What role can bispecific antibody therapy play in eliminating geographic and other medical disparities?
  • How is real world data affecting how bispecifics are administered?